budesonide inhalation

FDA Drug Profile — budesonide inhalation

budesonide inhalation is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including budesonide inhalation. Available dosage form: suspension.

Drug details

Generic Name
budesonide inhalation
Brand Names
budesonide inhalation
Application Number
ANDA210897
Sponsor
A-S Medication Solutions
NDC Codes
3
Dosage Forms
SUSPENSION
Routes
RESPIRATORY (INHALATION)
Active Ingredients
BUDESONIDE

Indications and Usage

1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age () Limitations of Use: Not indicated for the relief of acute bronchospasm () 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: • Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.